|
BnO-PEG6-OH
|
|
24342-68-5
|
|
(S)-Seco-Duocarmycin SA
|
|
152785-82-5
|
|
Mal-NH-ethyl-SS-propionic acid
|
|
2128735-24-8
|
|
AC1-IN-1
|
|
2762422-55-7
|
|
5-Iodotubercidin
|
|
24386-93-4
|
|
N-Boc-diethanolamine
|
|
103898-11-9
|
|
Doxorubicin-SMCC
|
|
400647-59-8
|
|
MC-Val-Ala-PAB-PNP
|
|
1639939-40-4
|
|
Mal-PEG2-VCP-Eribulin
|
|
2130869-18-8
|
|
Fmoc-Lys-OH hydrochloride
|
|
139262-23-0
|
|
Fmoc-8-amino-3,6-dioxaoctanoic acid
|
|
166108-71-0
|
|
CH 223191
|
|
301326-22-7
|
|
MMAD
|
|
203849-91-6
|
|
VcMMAE
|
|
646502-53-6
|
|
Val-Cit-PAB-MMAE
|
|
644981-35-1
|
|
DBCO-NHS ester
|
|
1353016-71-3
|
|
M2698
|
|
1379545-95-5
|
|
Vc-seco-DUBA
|
|
1345681-58-4
|
|
Deruxtecan
|
|
1599440-13-7
|
|
MAC glucuronide linker-2
|
|
229977-57-5
|
|
Mal-VC-PAB-DM1
|
|
1464051-44-2
|
|
Fipexide
|
|
34161-24-5
|
|
9-Cyclopentyladenine monomethanesulfonate
|
|
189639-09-6
|
|
INX-SM-56
|
|
2734878-18-1
|
|
Mal-C2-NHS ester
|
|
103750-03-4
|
|
McMMAF
|
|
863971-19-1
|
|
Auristatin E
|
|
160800-57-7
|
|
MMAF hydrochloride
|
|
1415246-68-2
|
|
Phe-Lys(Fmoc)-PAB
|
|
2149584-03-0
|
|
SPDB
|
|
115088-06-7
|
|
PC Biotin-PEG3-azide
|
|
1937270-46-6
|
|
Fmoc-Gly-Gly-Phe-OH
|
|
160036-44-2
|
|
(2-pyridyldithio)-PEG1-hydrazine
|
|
111625-28-6
|
|
Taltobulin trifluoroacetate
|
|
228266-41-9
|
|
Azido-PEG5-CH2CO2H
|
|
217180-81-9
|
|
PPC-NB
|
|
1887040-81-4
|
|
MC-Val-Ala-OH
|
|
1342211-31-7
|
|
Azido-PEG4-Val-Cit-PAB-MMAE
|
|
1869126-64-6
|
|
Maleimido-tri(ethylene glycol)-propionic acid
|
|
518044-40-1
|
|
N3-Ph-NHS ester
|
|
53053-08-0
|
|
Fmoc-NH-PEG4-CH2CH2COOH
|
|
557756-85-1
|
|
TASP0415914
|
|
1292300-75-4
|
|
Mal-Phe-C4-VC-PAB-MMAE
|
|
2259318-51-7
|
|
AKT-IN-3
|
|
2374740-21-1
|
|
ITE
|
|
448906-42-1
|
|
Fmoc-3VVD-OH
|
|
863971-44-2
|
|
DBCO-acid
|
|
1353016-70-2
|
|
Mal-PEG4-NHS ester
|
|
1325208-25-0
|
|
LRE1
|
|
1252362-53-0
|
|
11-Azidoundecanoic acid
|
|
118162-45-1
|
|
CL2-SN-38
|
|
1036969-20-6
|
|
MMAF sodium
|
|
1799706-65-2
|
|
Vipivotide tetraxetan Ligand-Linker Conjugate
|
|
1703768-74-4
|
|
SMCC
|
|
64987-85-5
|
|
AMPD2 inhibitor 1
|
|
2139356-35-5
|
|
MMAE-SMCC
|
|
2021179-11-1
|
|
Polatuzumab
|
|
2279068-37-8
|
|
OH-Glu-Val-Cit-PAB-MMAE
|
|
1895916-23-0
|
|
BMPS
|
|
55750-62-4
|
|
m-PEG2-Amine
|
|
31576-51-9
|
|
Mertansine
|
|
139504-50-0
|
|
BAY1125976
|
|
1402608-02-9
|
|
MC-VC-PABC-DNA31
|
|
1639352-03-6
|
|
N-(5-Hydroxypentyl)maleimide
|
|
180608-78-0
|
|
DBM-MMAF
|
|
1810001-93-4
|
|
DBCO-PEG4-VC-PAB-MMAE
|
|
2129164-91-4
|
|
6-Maleimidohexanoic acid N-hydroxysuccinimide ester
|
|
55750-63-5
|
|
Fmoc-NH-PEG3-CH2CH2COOH
|
|
867062-95-1
|
|
ABT 702 dihydrochloride
|
|
1188890-28-9
|
|
TDI-10229
|
|
2810887-45-5
|
|
Boc-Gly-Gly-Phe-Gly-OH
|
|
187794-49-6
|
|
Auristatin F
|
|
163768-50-1
|
|
Val-cit-PAB-OH
|
|
159857-79-1
|
|
Mal-PEG1-acid
|
|
760952-64-5
|
|
Propargyl-C1-NHS ester
|
|
132178-37-1
|
|
Mal-amido-PEG1-C2-NHS ester
|
|
1260092-50-9
|
|
TIP 39, Tuberoinfundibular Neuropeptide
|
|
277302-47-3
|
|
Gly3-VC-PAB-MMAE
|
|
2684216-48-4
|
|
Maleimide-DOTA
|
|
1006711-90-5
|
|
Lysipressin acetate
|
|
83968-49-4
|
|
MC-betaglucuronide-MMAE-1
|
|
1703778-92-0
|
|
DM21
|
|
2243689-80-5
|
|
SuO-Glu-Val-Cit-PAB-MMAE
|
|
1895916-24-1
|
|
PROTAC BRD4 Degrader-10
|
|
2417370-49-9
|
|
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT
|
|
2378428-19-2
|
|
MCC-DM1
|
|
1100692-14-5
|
|
Methotrexate-d3
|
|
432545-63-6
|
|
Bi-Mc-VC-PAB-MMAE
|
|
1620837-70-8
|
|
Glembatumumab
|
|
1020264-78-1
|
|
Deruxtecan analog 2
|
|
1599440-10-4
|
|
DBCO-PEG4-Val-Cit-PAB-MMAF
|
|
2244602-23-9
|
|
Recilisib
|
|
334969-03-8
|
|
Ac-Lys-Val-Cit-PABC-MMAE
|
|
1650569-89-3
|
|
alpha-GalNAc-TEG-N3
|
|
882873-70-3
|
|
MC-VA-PABC-MMAE
|
|
1818864-51-5
|
|
Vipivotide tetraxetan
|
|
1702967-37-0
|
|
Indole-C2-amide-C2-NH2
|
|
215789-29-0
|
|
Fmoc-NH-PEG1-CH2COOH
|
|
260367-12-2
|
|
Mal-(CH2)5-Val-Cit-PAB-Eribulin
|
|
2130869-21-3
|
|
AlexaFluor350NHSester
|
AF350NHS活化酯
|
200554-19-4
|